Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor

Journal of Medicinal Chemistry
1994.0

Abstract

Benzodiazepines (BZ) exert their effects through GABAA receptors, which belong to the superfamily of ligand-gated ion channels. Coexpression of recombinant alpha, beta, and gamma subunits in a cell culture system mimics the BZ binding sites. The alpha variants largely determine the nature of the BZ binding site in such alpha i beta j gamma k heteromultimers (i = 1-6; j = 1-3; k = 1-3). Notably, the alpha 1 and alpha 6 variants confer high and low affinity for BZ agonists to the resulting receptor subtype, respectively. Glycine/glutamate and histidine/arginine positions in the alpha subunits of alpha x beta 2 gamma 2 receptors are involved in BZ I versus BZ II type selectivity. We now identify four amino acids in alpha 6 which together increase the affinity of the mutant alpha x beta 2 gamma 2 receptor for classical BZ receptor agonists above the level seen for any wild-type GABAA/BZ receptor. The most pronounced effect was due to an isoleucine to valine exchange. It simultaneously decreased the affinity for the BZ partial inverse agonist Ro 15-4513 20-fold and increased the affinity for diazepam 4-fold. The four amino acid residues stretch over most part of the N-terminal extracellular domain of the alpha subunit, suggesting that amino acids distant in the primary sequence form the BZ binding pocket.

Knowledge Graph

Similar Paper

Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor
Journal of Medicinal Chemistry 1994.0
Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies
Bioorganic & Medicinal Chemistry Letters 2022.0
Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) Modulators Acting at the Benzodiazepine Binding Site: An Update
Journal of Medicinal Chemistry 2020.0
Pharmacophore/Receptor Models for GABA<sub>A</sub>/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach
Journal of Medicinal Chemistry 2000.0
Selective Influence on Contextual Memory: Physiochemical Properties Associated with Selectivity of Benzodiazepine Ligands at GABA<sub>A</sub>Receptors Containing the α5 Subunit
Journal of Medicinal Chemistry 2008.0
N-(Indol-3-ylglyoxylyl)piperidines: high affinity agonists of human GABA-A receptors containing the α1 subunit
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
A Novel Selective GABA<sub>A</sub>α1 Receptor Agonist Displaying Sedative and Anxiolytic-like Properties in Rodents
Journal of Medicinal Chemistry 2005.0
Novel N-Substituted Indol-3-ylglyoxylamides Probing the L<sub>Di</sub>and L<sub>1</sub>/L<sub>2</sub>Lipophilic Regions of the Benzodiazepine Receptor Site in Search for Subtype-Selective Ligands
Journal of Medicinal Chemistry 2007.0
3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and Analogues:  High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1
Journal of Medicinal Chemistry 2004.0
Synthesis of GABA<sub>A</sub>Receptor Agonists and Evaluation of their α-Subunit Selectivity and Orientation in the GABA Binding Site
Journal of Medicinal Chemistry 2008.0